Ten years' disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy A case report and literature review

被引:2
|
作者
Zhang, Jue [1 ]
Mei, Liejun [2 ]
Wang, Fubing [3 ]
Li, Yan [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan 430071, Peoples R China
基金
北京市自然科学基金;
关键词
advanced ovarian cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis; HIPEC; PACLITAXEL; CISPLATIN;
D O I
10.1097/MD.0000000000023404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. Patient concerns: A fifty-year-old patient had a chief complaint of an abdominal distension lasting 1 month. Diagnoses: The patient was diagnosed with advanced epithelial ovarian cancer with peritoneal carcinomatosis by computed tomography scan, tumor markers, endoscopy examination, and pathology. Interventions: The patient was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy followed by 8 cycles of systemic chemotherapy. Outcomes: Till March 9, 2020, the patient has disease-free survival over 10 years. Lessons: The application of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy combined with systematic chemotherapy may improve survival dramatically for the patients with epithelial ovarian cancer and peritoneal carcinomatosis and should be considered as an option of a relatively new regime.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] OVERALL AND DISEASE-FREE SURVIVAL IN PATIENTS WITH CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN CANCER A SEVEN YEAR RETROSPECTIVE STUDY
    Ramavath, K. K.
    Sekhon, R.
    Rawal, S.
    Jaipuria, J.
    Sehra, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 15 - 16
  • [2] Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer
    Zhang, Jue
    Li, Xin-Bao
    Ma, Ru
    Ji, Zhong-He
    Bai, Wenpei
    Li, Yan
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (08) : 3705 - +
  • [3] Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Chambers, Laura M.
    Yao, Meng
    Morton, Molly
    Gruner, Morgan
    Chichura, Anna
    Horowitz, Max
    Costales, Anthony B.
    Rose, Peter G.
    Michener, Chad M.
    Debernardo, Robert
    GYNECOLOGIC ONCOLOGY, 2021, 161 (02) : 389 - 395
  • [4] Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    Helm, C. William
    Bristow, Robert E.
    Kusamura, Shigeki
    Baratti, Dario
    Deraco, Marcello
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (04) : 283 - 290
  • [5] Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Intraoperative Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer
    Tentes, Antonios-Apostolos K.
    Kakolyris, Stylianos
    Kyziridis, Dimitrios
    Karamveri, Christina
    JOURNAL OF ONCOLOGY, 2012, 2012
  • [6] The impact of BMI extremes on disease-free survival and overall survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Naffouje, Amer A.
    Tulla, Kiara A.
    Khalaf, Zaynab
    Salti, George, I
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (02) : 194 - 202
  • [7] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: State of the art
    Ramez N Eskander
    Luca Ansaloni
    Robert E Bristow
    Federico Coccolini
    World Journal of Obstetrics and Gynecology, 2013, (04) : 94 - 100
  • [8] Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer
    Frankinet L.
    Bhatt A.
    Alcazer V.
    Classe J.-M.
    Bereder J.-M.
    Meeus P.
    Pomel C.
    Mithieux F.
    Abboud K.
    Wermert R.
    Lavoue V.
    Marchal F.
    Glehen O.
    Bakrin N.
    Annals of Surgical Oncology, 2023, 30 (6) : 3287 - 3299
  • [9] CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY IMPROVES SURVIVAL IN PATIENTS WITH STAGE IIIC OVARIAN CANCER
    Li, Zhen
    Cai, Hongbing
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 233 - 233
  • [10] Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
    Ansaloni, Luca
    Agnoletti, Vanni
    Amadori, Andrea
    Catena, Fausto
    Cavaliere, Davide
    Coccolini, Federico
    De Iaco, Pierandrea
    Di Battista, Monica
    Framarini, Massimo
    Gazzotti, Filippo
    Ghermandi, Claudio
    Kopf, Barbara
    Saponara, Maristella
    Tauceri, Francesca
    Vallicelli, Carlo
    Verdecchia, Giorgio Maria
    Pinna, Antonio Daniele
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 778 - 785